PROS1 and infection: The power of this approach was demonstrated by its ability to identify a conserved region within the SARS-CoV-2 S protein, which must undergo large-scale mechanical rearrangements to enable infection of human cells, and then to leverage this knowledge to develop and experimentally validate a new class of orally bioavailable coronavirus inhibitors that target this site.